BD, 752802, BV750 Mouse Anti-Human TCR Vβ9 AMKB1-2
50 µg
Catalog Number: 752802
Send a RFQ.
Category
| Source | Mouse IFN alpha A, amino acids (Cys24 - Glu190) (Accession # NM_206870), was expressed in E. coli. |
|---|---|
| Molecular Mass | The 167 amino acid recombinant protein has a predicted molecular mass of approximately 19.3 kD. The protein migrates at approximately 20 kD in DTT-reducing conditions and at approximately 17 kD in non-reducing conditions by SDS-PAGE. The predicted N-terminal amino acid is Cys. |
| Purity | >95%, as determined by Coomassie stained SDS-PAGE. |
| Formulation | 0.22 µm filtered protein solution is in PBS, pH 7.2. |
| Endotoxin Level | Less than 0.01 ng per µg cytokine as determined by the LAL method. |
| Concentration | 10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool. |
| Storage & Handling | Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles. |
| Activity | Recombinant Mouse IFN-α induces CCL2 (MPC-1) in Raw264.7 cells in a dose dependent manner. The ED50 range for this effect is 0.04 – 0.4 µg/mL |
|---|
| Application | Bioassay |
|---|
| Application Notes | BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at [email protected]. |
|---|
| Product Citations | Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed Humeau J, et al. 2020. EMBO Mol Med. 12:e11622. PubMed Holay N, et al. 2023. Front Immunol. 13:1047661. PubMed Luo H, et al. 2023. JCI Insight. 8:. PubMed Pang W, et al. 2023. iScience. 26:106579. PubMed Fukao S, et al. 2021. Elife. 10:. PubMed Xiang H, et al. 2022. Cancer Sci. 113:2513. PubMed Asano T, et al. 2022. J Clin Lipidol. 17:78. PubMed Lu YN, et al. 2021. PLoS Biol. 19:e3001096. PubMed Jiao H, et al. 2020. Nature. 580:391. PubMed Eissa IR, et al. 2021. Int J Cancer. 149:214. PubMed Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed Maroun JW, et al. 2020. Mol Ther Oncolytics. 0.913888889. PubMed Ho WW, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Kalliara E, et al. 2022. Front Immunol. 13:947213. PubMed Schafer JB, et al. 2022. J Biol Chem. :102694. PubMed |
|---|
| Structure | Cytokine. |
|---|
| Distribution | Monocytes/macrophages, fibroblasts, lymphoblastoid cells, and a variety of cell types following induction by viruses. IFN-α is also induced by nucleic acids, glucocorticoid hormones, n-butyrate, and 5-bromodeoxy uridine in different cells. |
|---|
| Function | IFN-α stimulates cytotoxic T lymphocytes and natural killer cell function. IFN-α has immunomodulatory and antiviral properties. |
|---|
| Interaction | Varieties of cells express the IFNα receptor (IFNAR). |
|---|
| Ligand/Receptor | IFNAR complex has two components: IFNAR1 and IFNAR2. |
|---|
| Bioactivity | Cytopathic effect inhibition assay using EMC virus on L929 cells. |
|---|
| Biology Area | Immunology, Innate Immunity |
|---|
| Molecular Family | Cytokines/Chemokines |
|---|
| Antigen References | 1. Siren J, et al. 2005. J. Immunol. 174:1932. 2. Bose A, Baral R. 2007. Immunol. Lett. 108:68. 3. Zhao W, et al. 2008. J. Immunol. 180:5483. 4. Sadler AJ, Williams BR. 2008. Nat. Rev. 8:559. 5. BjorcK P, et al. 2011. J. Immunol. 186:1477. 6. Badiger R, et al. 2012. PLoS One 7:e46779. 7. Aghemo A, et al. 2010. Nat. Rev. Gastroenterol. Hepatol. 7:485. 8. Mukherjee KK, et al. 2012. Indian J. Med. Res. 136:54. 9. Becker-Merok A, et al. 2013. Lupus 22:155. |
|---|
| Gene ID | 242517 |
|---|
| UniProt | View information about IFN-alpha on UniProt.org |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Mus musculus interferon alpha 15 (Ifna15), MuIFN-alpha-A, Ifnaa, IFN-alpha, IFNa, IFN-a |
|---|